Toda I, Kawahara T, Murakawa Y, Nozaki A, Kawakubo K, Inoue H, Sugimoto T
Second Department of Internal Medicine, University of Tokyo, Japan.
Br Heart J. 1989 Mar;61(3):268-73. doi: 10.1136/hrt.61.3.268.
Electrophysiological studies were performed in eight patients (four men and four women, mean (SD) age 24 (5) years with paroxysmal attacks of palpitation during or immediately after exercise. Five patients were competitive athletes at college. In two patients spontaneous supraventricular tachycardia during exercise was recorded by ambulatory electrocardiographic monitoring and in another it was induced by treadmill exercise testing. Two had dual atrioventricular nodal pathways, three had manifest atrioventricular accessory pathways, and three had concealed atrioventricular pathways. Programmed stimulation induced sustained supraventricular tachycardia in six patients--in two after intravenous injection of atropine sulphate (1 mg) and in four during infusion of isoprenaline (0.01 microgram/kg/min). In one patient, non-sustained atrioventricular nodal reentrant tachycardia was induced during isoprenaline infusion. In the remaining patient, who had dual atrioventricular nodal pathways, tachycardia was not inducible. AH block prevented maintenance of reentry in five patients. In five patients shortening of the effective refractory period of the atrioventricular node with atropine (one patient) and isoprenaline (four patients) caused sustained supraventricular tachycardia. The present study indicates that treatment with atropine and isoprenaline may be an important factor in the initiation of supraventricular tachycardia in patients with exercise related paroxysms of palpitation.
对8例患者(4男4女,平均(标准差)年龄24(5)岁)进行了电生理研究,这些患者在运动期间或运动后立即出现心悸阵发性发作。5例患者为大学竞技运动员。2例患者通过动态心电图监测记录到运动期间自发的室上性心动过速,另1例通过跑步机运动试验诱发。2例有双房室结径路,3例有显性房室旁道,3例有隐匿性房室旁道。程控刺激使6例患者诱发持续性室上性心动过速——2例在静脉注射硫酸阿托品(1mg)后,4例在输注异丙肾上腺素(0.01μg/kg/min)期间。1例患者在输注异丙肾上腺素期间诱发非持续性房室结折返性心动过速。在其余1例有双房室结径路的患者中,未能诱发心动过速。房室结阻滞阻止了5例患者折返的维持。在5例患者中,阿托品(1例患者)和异丙肾上腺素(4例患者)使房室结有效不应期缩短,从而导致持续性室上性心动过速。本研究表明,阿托品和异丙肾上腺素治疗可能是与运动相关心悸阵发性发作患者发生室上性心动过速的一个重要因素。